Articles dans des revues avec comité de lecture (400)
  1. 356. Eizirik, D. L., & Sandler, S. (1989). Sustained exposure of toxically damaged mouse pancreatic islets to high glucose does not increase beta-cell dysfunction. Journal of Endocrinology, 123(1), 47-51.
  2. 357. Jansson, L., Eizirik, D. L., & Sandler, S. (1989). Terbutaline decreases the blood flow of the pancreatic islets but does not reduce the diabetogenic action of streptozotocin in the rat. European journal of pharmacology, 161(1), 79-83.
  3. 358. Strandell, E., Eizirik, D. L., & Sandler, S. (1989). Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide. Experimental and clinical endocrinology, 93(2-3), 219-224. doi:10.1055/s-0029-1210860
  4. 359. Sandler, S., Bendtzen, K., Borg, L. A., Eizirik, D. L., Strandell, E., & Welsh, N. (1989). Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function. Endocrinology, 124(3), 1492-1501.
  5. 360. Eizirik, D. L., & Sandler, S. (1989). Function and metabolism of pancreatic beta-cells maintained in culture following experimentally induced damage. Pharmacology & toxicology, 65(3), 163-168.
  6. 361. Eizirik, D. L., Sandler, S., Korsgren, O., Jansson, L., & Andersson, A. (1989). Persistent impairment of the insulin response to glucose both in vivo and in vitro after streptozotocin exposure: studies with grafted pancreatic islets and islets maintained in culture. Acta endocrinologica (Print ed.), 121(6), 849-856.
  7. 362. Sandler, S., Bendtzen, K., Eizirik, D. L., Sjöholm, A., & Welsh, N. (1989). Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1 beta. Immunology letters, 22(4), 267-272.
  8. 363. Eizirik, D. L., & Sandler, S. (1989). Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events. Diabetologia, 32(11), 769-773.
  9. 364. Eizirik, D. L., Sandler, S., Hallberg, A., Bendtzen, K., Sener, A., & Malaisse, W. (1989). Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta. Endocrinology, 125(2), 752-759. doi:10.1210/endo-125-2-752
  10. 365. Eizirik, D. L., Strandell, E., & Sandler, S. (1988). Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia, 31(3), 168-174.
  11. 366. Welsh, N., Eizirik, D. L., & Strandell, E. (1988). Heat-shock treatment of mouse pancreatic islets results in a partial loss of islet cells but no remaining functional impairment among the surviving beta cells. Journal of molecular endocrinology, 1(1), 27-31.
  12. 367. Eizirik, D. L., & Sandler, S. (1988). Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan. Pharmacology & toxicology, 63(5), 396-399.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 Suivant >>